Cited 10 times in
Favorable outcome of alternate systemic and intra-arterial chemotherapy for retinoblastoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김동준 | - |
dc.contributor.author | 유철주 | - |
dc.contributor.author | 이성철 | - |
dc.contributor.author | 한승민 | - |
dc.contributor.author | 한정우 | - |
dc.date.accessioned | 2017-02-24T11:21:45Z | - |
dc.date.available | 2017-02-24T11:21:45Z | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 0888-0018 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/146745 | - |
dc.description.abstract | The recent trend of treatment for retinoblastoma is to salvage the eye globes as well as achieving patients' survival. Intra-arterial chemotherapy (IAC) is one of the current standard treatment; however, it cannot exclude the risk of occult micrometastases in the central nervous system in advanced-stage retinoblastoma. Alternate fashion of intravenous chemotherapy (IVC) and IAC strategy was developed to increase the eye salvage rate and to reduce the metastatic risk. Between January 2012 and December 2014, 13 eyes of 12 patients with newly diagnosed retinoblastoma received alternate chemotherapy using IVC and IAC in Yonsei Cancer Center. Eye salvage rate was assessed by the eye preservation time, which was defined as the duration from the diagnosis to the time of enucleation. Total 13 eyes were classified according to the International Classification of Retinoblastoma (ICRB) as group B (n = 1, 7.7%), group C (n = 2, 15.4%), group D (n = 5, 38.5%), or group E (n = 5, 38.5%). IAC was performed, 3 to 5 times (median: 4 times) for each eye, total 54 times. Five to 15 courses (median: 8 courses) of systemic chemotherapy were performed in the patients. During the median follow-up period of 30.4 months, overall eye salvage rate was 63.9 ± 14.7%. All patients survived. The treatment was tolerable without significant complications. These results showed that primary alternate IVC-IAC was tolerable and effective for retinoblastoma. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.format.extent | 74~82 | - |
dc.language | English | - |
dc.publisher | Informa Healthcare | - |
dc.relation.isPartOf | PEDIATRIC HEMATOLOGY AND ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Child, Preschool | - |
dc.subject.MESH | Eye Neoplasms/classification | - |
dc.subject.MESH | Eye Neoplasms/drug therapy* | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Infant | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Retinoblastoma/classification | - |
dc.subject.MESH | Retinoblastoma/drug therapy* | - |
dc.title | Favorable outcome of alternate systemic and intra-arterial chemotherapy for retinoblastoma | - |
dc.type | Article | - |
dc.publisher.location | England | - |
dc.contributor.college | College of Medicine | - |
dc.contributor.department | Dept. of Radiology | - |
dc.contributor.googleauthor | Seung Min Hahn | - |
dc.contributor.googleauthor | Hyo Sun Kim | - |
dc.contributor.googleauthor | Dong Joon Kim | - |
dc.contributor.googleauthor | Sung Chul Lee | - |
dc.contributor.googleauthor | Chuhl Joo Lyu | - |
dc.contributor.googleauthor | Jung Woo Han | - |
dc.identifier.doi | 10.3109/08880018.2015.1135363 | - |
dc.contributor.localId | A00410 | - |
dc.contributor.localId | A02524 | - |
dc.contributor.localId | A02873 | - |
dc.contributor.localId | A04299 | - |
dc.contributor.localId | A04325 | - |
dc.relation.journalcode | J02890 | - |
dc.identifier.eissn | 1521-0669 | - |
dc.identifier.pmid | 26901285 | - |
dc.identifier.url | http://www.tandfonline.com/doi/abs/10.3109/08880018.2015.1135363 | - |
dc.subject.keyword | Chemotherapy | - |
dc.subject.keyword | infusions | - |
dc.subject.keyword | intra-arterial | - |
dc.subject.keyword | retinoblastoma | - |
dc.contributor.alternativeName | Kim, Dong Joon | - |
dc.contributor.alternativeName | Lyu, Chuhl Joo | - |
dc.contributor.alternativeName | Lee, Sung Chul | - |
dc.contributor.alternativeName | Hahn, Seung Min | - |
dc.contributor.alternativeName | Han, Jung Woo | - |
dc.contributor.affiliatedAuthor | Kim, Dong Joon | - |
dc.contributor.affiliatedAuthor | Lyu, Chuhl Joo | - |
dc.contributor.affiliatedAuthor | Lee, Sung Chul | - |
dc.contributor.affiliatedAuthor | Hahn, Seung Min | - |
dc.contributor.affiliatedAuthor | Han, Jung Woo | - |
dc.citation.volume | 33 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 74 | - |
dc.citation.endPage | 82 | - |
dc.identifier.bibliographicCitation | PEDIATRIC HEMATOLOGY AND ONCOLOGY, Vol.33(1) : 74-82, 2016 | - |
dc.date.modified | 2017-02-24 | - |
dc.identifier.rimsid | 47488 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.